Sanofi India Limited — Others, 12-08-2025: Shareholders meeting
Sanofi India is seeking shareholder approval via postal ballot for key leadership changes. The Board has proposed Mr. Rachid Ayari as the Interim Managing Director for a six-month term or until a permanent MD is appointed. He will continue as Whole-time Director and CFO without additional pay for this interim role. Additionally, the company has appointed Mr. Mahadev Gawade as an Additional Director and is now seeking member approval for his appointment as a Director and Whole-time Director for three years. His proposed annual remuneration includes a basic salary of ₹0.56 Cr and a special allowance of ₹0.47 Cr, plus a performance bonus of up to ₹0.28 Cr. These appointments aim to ensure strong leadership continuity and operational expertise.
